From: High-dose-rate brachytherapy using molds for lip and oral cavity tumors
Characteristic | Values |
---|---|
Age (years) | |
Median | 80.0 |
Range | 59-94 |
≤ 70 | 3 |
> 70 | 14 |
Gender | |
Male | 10(58.8%) |
Female | 7(41.2%) |
ECOG Performance status | |
0 | 4(23.5%) |
1 | 9(53.0%) |
2 | 4(23.5%) |
Tumor site | |
Buccal mucosa | 8(47.1%) |
Gingiva | 3(17.6%) |
Lip | 2(11.8%) |
Floor of the mouth | 2(11.8%) |
Hard palate | 2(11.8%) |
T stage | |
T1 | 1(5.9%) |
T2 | 11(64.7%) |
T3 | 5(29.4%) |
N stage | |
N0 | 15(88.2%) |
N1 | 1(5.9%) |
N2b | 1(5.9%) |
Stage | |
I | 1(5.9%) |
II | 9(52.9%) |
III | 6(35.3%) |
IVA | 1(5.9%) |